# US 2006/0153923 A1 · Nanoparticles of polypoxyethylenated derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153923 A1
- Document ID: US20060153923A1
- Status: Published application
- Kind: A1
- Application number: 10/563,031
- Filed: 2004-06-17
- Published: 2006-07-13
- Earliest claimed: 2003-07-04
- Inventors: Maria Jose Fernandez; Alejandro Barreiro; Noemi Csaba
- Web page: https://patentgrep.com/patent/US20060153923A1

## CPC

- A61K 9/5146: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides}
- A61K 9/5153: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61K 9/5192: {Processes}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention relates to nanoparticles of polyoxyethylenated derivatives, having a size of less than 1 micrometer, for the administration of pharmaceutically- or cosmetically-active ingredients. The inventive nanoparticles comprise a biodegradable polymer, a polyoxyethylene-derived block copolymer and at least one pharmaceutically- or cosmetically-active ingredient. The invention further relates to the method of obtaining the aforementioned nanoparticles and to compositions containing same.

## Claims

### Claim 1

A method of preparing nanoparticles, having a size of less than 1 μm, for the administration of active ingredients, comprising the steps of:
a) dissolving a biodegradable polymer together with a polyoxyethylene-derived block copolymer in an organic solvent, the weight ratio of both polymers being between 1:0.1 and 1:3;
b) adding, with stirring, the solution obtained to a polar phase, wherein the biodegradable polymer has low solubility, precipitating the polymer and forming the nanoparticles;
c) eliminating the organic solvent; and
d) isolating the particles,
wherein the active ingredient is dissolved in the organic solvent used in a) before or after step a), or is dissolved in a small volume of the aqueous phase, which is then dispersed in the organic solvent used in a), before or after step a).

### Claim 2 (depends on 1)

A method according to claim 1, further comprising lyophilizing the nanoparticles obtained.

### Claim 3 (depends on 1)

A method according to claim 1, wherein the biodegradable polymer comprises a polyester.

### Claim 4 (depends on 1)

A method according to claim 1, wherein the biodegradable polymer comprises a polyanhydride.

### Claim 5 (depends on 3)

A method according to claim 3, wherein the polyester is selected from among polycaprolactone, polylactic acid, polylactic co-glycolic acid and their mixtures.

### Claim 6 (depends on 1)

A method according to claim 1, wherein the block copolymer comprises a poloxamer.

### Claim 7 (depends on 6)

A method according to claim 6, wherein the poloxamer has a molecular weight comprised between 1,000 and 25,000 Daltons.

### Claim 8 (depends on 1)

A method according to claim 1, wherein the block copolymer is a poloxamine.

### Claim 9 (depends on 8)

A method according to claim 8, wherein the poloxamine has a molecular weight comprised between 1,000 and 25,000 Daltons.

### Claim 10 (depends on 1)

A method according to claim 1, wherein the active ingredient is selected from molecules with therapeutic properties, vaccines and cosmetic ingredients.

### Claim 11 (depends on 1)

A method according to claim 1, wherein the weight ratio of both polymers is between 1:1 and 1:3.

### Claim 12 (depends on 1)

Nanoparticles for the administration of pharmaceutically- or cosmetically-active ingredients, having a size of less than 1 μm, as produced by the method of claim 1.

### Claim 13 (depends on 2)

Lyophilized nanoparticles for the administration of pharmaceutically- or cosmetically-active ingredients, having a size of less than 1 μm, as produced by the method of claim 2.

### Claim 14 (depends on 12)

A composition comprising nanoparticles according to claim 12.

### Claim 15 (depends on 12)

A pharmaceutical or cosmetic composition comprising nanoparticles according to claim 12.

### Claim 16 (depends on 13)

A composition comprising nanoparticles according to claim 13.

### Claim 17 (depends on 13)

A pharmaceutical or cosmetic composition comprising nanoparticles according to claim 13.
